Oraya Therapeutics, Inc.

CLOSED

3 Twin Dolphin Dr Ste 175, 加利福尼亚州阿拉梅达县, California, United Stateswww.orayainc.comPrivate51–100 employeesEstablished: 2007-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2007

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

50.0%

Phase 2

33.3%

Phase 1

16.7%

Trial Status Distribution

Completed

16.7%

Unknown

66.7%

Withdrawn

16.7%

Clinical Trials

Trials sponsored by this organization (6)

An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Phase 2

Unknown

interventional

Sep 2012500 participants

Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration

Not Applicable

Unknown

interventional

Aug 201212 participants

IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD

Not Applicable

Unknown

interventional

Jan 201212 participants

Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)

INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD

Phase 2

Completed

interventional

Nov 2009230 participants

Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Phase 1

Unknown

interventional

Jul 200862 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations